All News
Filter News
Found 809,020 articles
-
Curis, Inc. Announces Agreement with The Leukemia & Lymphoma Society to Develop CUDC-907 for Lymphoma and Multiple Myeloma
11/30/2011
-
Asterand plc's Subsidiary BioSeek Achieves a Research Milestone in Drug Discovery Collaboration With Ono Pharmaceutical Company, Ltd.
11/30/2011
-
Cognizant to Deliver Comprehensive Biostatistics and Medical Reporting Services for AstraZeneca PLC
11/30/2011
-
The Conditas Group Signs Exclusive US Business Development Deal for Medicinal Chemistry and Drug Discovery Services with Melbourne and Shanghai Based Synthesis Med Chem USA for Medicinal Chemistry and Drug Discovery Services
11/30/2011
-
Tobii Technology AB Partners with Friedman to Expand Use of Eye Tracking in Consumer Goods Market Research
11/30/2011
-
Emboline Receives U.S. Allowance for Key Piece of Its Seminal Patent Portfolio of Aortic Embolic Protection Technologies for Percutaneous Heart Valve Procedures Such as TAVR
11/30/2011
-
Orexo AB and Uppsala Universitet Receive Swedish Research Council Grant for Bioceramics Project
11/30/2011
-
Onconova Therapeutics Inc. Selects BioClinica, Inc. Express
11/30/2011
-
Amarantus BioSciences, Inc. Receives Grant from Brewer Sports International for Traumatic Brain Injury
11/30/2011
-
Cannabis Science Inc. Confirms Two Extract-Based Formulations are Both Available Now at Cannabis Therapeutics and Marisol Therapeutics in Colorado
11/30/2011
-
Octapharma USA, Inc. Announces Octagam® 5% Again Available for U.S. Purchase
11/30/2011
-
Eisai Company, Ltd. Announce Japan Launch of Oral Anticoagulant Warfarin Granules 0.2%
11/30/2011
-
Elan Corporation PLC Provides an Update on ELND005 (Scyllo-inositol)
11/30/2011
-
United States Patent and Trademark Office Upholds Key Santaris Pharma A/S LNA Patents in Two Re-Examination Cases Brought by Isis Pharmaceuticals, Inc.
11/30/2011
-
NephRx Corporation Awarded U.S. Patent for NX002 for Treatment of Oral Mucositis
11/30/2011
-
BIOLASE Technology, Inc. Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts and Glaucoma
11/30/2011
-
Dilon Diagnostics Release; BSGI/MBI Proven to Be Equivalent to MRI in the Detection of Breast Cancer
11/30/2011
-
InVitria Successfully Completes National Institutes of Health (NIH) Grant for Animal-Free Media Supplements
11/30/2011
-
Extraordinary General Meeting of Shareholders of Basilea Pharmaceutica
11/30/2011
-
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) to Remain Listed on The NASDAQ Global Market
11/30/2011